Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Interest Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Interest Expenses for 11 consecutive years, with $132000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 220.0% to $132000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67000.0 through Dec 2025, down 71.0% year-over-year, with the annual reading at $67000.0 for FY2025, 71.0% down from the prior year.
  • Interest Expenses for Q4 2025 was $132000.0 at Jaguar Health, up from $6000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $4.2 million in Q1 2022, with the low at -$162000.0 in Q3 2024.
  • Average Interest Expenses over 5 years is $1.2 million, with a median of $500000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses surged 209600.0% in 2022, then tumbled 144.35% in 2024.
  • Over 5 years, Interest Expenses stood at $2.4 million in 2021, then increased by 8.26% to $2.6 million in 2022, then tumbled by 90.58% to $248000.0 in 2023, then plummeted by 144.35% to -$110000.0 in 2024, then surged by 220.0% to $132000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $132000.0, $6000.0, and -$15000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.